FDA Orders Stronger Warning About Diabetes Drug Invokana and Amputations
The U.S. Food and Drug Adminstration is calling attention to the risk of amputation if you’re on the drug Canagliflozin (Invokana, Invokamet), a common type 2 diabetes medication.
On May 16, 2017, the FDA concluded that the Type 2 diabetes medication Canagliflozin (Invokana, Invokamet and Invokamet XR) causes an increased risk of leg and foot amputations. The FDA will now require the most prominent black box warning to be added to the Canagliflozin drug labels. This new warning came at the conclusion of two large clinical trials, one of which showed that leg and foot amputations occurred about twice as often in patients treated with Canagliflozin versus a placebo.
Clark Law Firm is currently investigationg these cases and committed to assisting in these cases on behalf of patients who have suffered an amputation.
If you have been effected by this drug, the Clark Law Firm may be able to help you. Contact our office at 732-443-0333 or on our Contact Page.-1